Posts

Posted on

T-Mobile Agrees to Sell $3.0 Billion of Senior Notes

T-Mobile Agrees to Sell $3.0 Billion of Senior Notes

BELLEVUE, Wash.–(BUSINESS WIRE)–
T-Mobile US, Inc. (NASDAQ: TMUS) (“T-Mobile”) announced today that T-Mobile USA, Inc., its direct wholly-owned subsidiary (“T-Mobile USA” or the “Issuer”), has agreed to sell $1,000,000,000 aggregate principal amount of 2.250% Senior Notes due 2026 (the “2026 notes”), $1,000,000,000 aggregate principal amount of 2.625% Senior Notes due 2029 (the “2029 notes”) and $1,000,000,000 aggregate principal amount of 2.875% Senior Notes due 2031 (the “2031 notes” and together with the 2026 notes and the 2029 notes, the “notes”) in a registered public offering. The offering of the notes is scheduled to close on January 14, 2021, subject to satisfaction of customary closing conditions.

T-Mobile USA intends to use the net proceeds from the offering of the notes for general corporate purposes, which may include among other things, financing acquisitions of additional spectrum and refinancing existing indebtedness on an ongoing basis.

Deutsche Bank Securities Inc., Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC, Goldman Sachs & Co. LLC, Barclays Capital Inc., J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and RBC Capital Markets, LLC are the joint book-running managers for the offering of the notes. Academy Securities, Inc., C.L. King & Associates, Inc., Great Pacific Securities and Mischler Financial Group, Inc. are acting as co-managers.

The Issuer has filed a registration statement (including a prospectus) with the Securities and Exchange Commission (“SEC”) for the offering of notes to which this communication relates. Before you invest, you should read the prospectus in that registration statement and the related prospectus supplement and other documents the Issuer will file with the SEC for more complete information about the Issuer and the offering of the notes. You may get these documents for free by visiting EDGAR on the SEC Web site at http://www.sec.gov. Alternatively, the Issuer, any underwriter or any dealer participating in the offering of the notes will arrange to send you the prospectus and related prospectus supplement if you request it by contacting Deutsche Bank Securities Inc., Attention: Prospectus Group, 60 Wall Street, New York, New York 10005-2836, by telephone at (800) 503-4611 or by email at [email protected]; Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by phone at (800) 831- 9146; Credit Suisse Securities (USA) LLC, Attn: Prospectus Department, 6933 Louis Stephens Drive, Morrisville, North Carolina 27560, 1-800-221-1037, [email protected]; Goldman Sachs & Co. LLC, 200 West Street, New York, New York 10282, Attn: Prospectus Department, Telephone 212-902-1171, Email: [email protected]; Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, [email protected], (888) 603-5847; J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, Phone: 631-254-1735; Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, Second Floor, New York, New York 10014 or RBC Capital Markets, LLC, 200 Vesey Street, 8th Floor New York, New York 10281, Attention: Leveraged Capital Markets; by telephone at 1-877-280-1299.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the notes or any other securities, nor shall it constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale is unlawful.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements that are based on T-Mobile management’s current expectations. Such statements include, without limitation, statements about the expected closing of the offering of the notes and statements regarding the intended use of proceeds from the offering of the notes. Such forward-looking statements are subject to certain risks, uncertainties and assumptions, including, without limitation, prevailing market conditions, difficulties in executing the offering of the notes and other factors. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those expected. More information about potential risk factors that could affect T-Mobile and its results is included in T-Mobile’s filings with the SEC, which are available at http://www.sec.gov.

T-Mobile US

Media Relations

[email protected]

or

Investor Relations:

[email protected]

KEYWORDS: Washington United States North America

INDUSTRY KEYWORDS: Mobile/Wireless Technology Telecommunications

MEDIA:

Logo
Logo
Posted on

Theratechnologies Announces US$40 Million Bought-deal Public Offering of Units

MONTREAL, Jan. 11, 2021 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX) ), a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that it has entered into an agreement with a syndicate of Canadian underwriters (collectively, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a bought-deal basis, 14,546,000 units of the Company (the “Units”) for aggregate gross proceeds to the Company of US$40,001,500 (equivalent to approximately C$51,081,915) (the “Offering“) at a price of US$2.75 per Unit (equivalent to approximately C$3.51 per Unit).

Each Unit shall be comprised of one common share of the Company (each a “Common Share“) and one-half of one Common Share purchase warrant of the Company (each whole warrant, a “Warrant“). Each Warrant shall entitle the holder thereof to purchase one Common Share at an exercise price of US$3.18 (equivalent to approximately C$4.06) at any time up to 36 months from the closing of the Offering.

The Company has granted to the Underwriters an option (the “Over-Allotment Option”) to increase the size of the Offering by up to an additional number of Units, and/or the components thereof, that in aggregate would be equal to 15% of the total number of Units to be issued under the Offering, to cover over-allotments, if any, and for market stabilization purposes, exercisable at any time and from time to time up to 30 days following the closing of the Offering.

The net proceeds from the Offering will be used primarily to fund research and development activities, commercialisation initiatives, general and administrative expenses, working capital needs and other general corporate purposes.

The closing of the Offering is expected to occur on or about January 19, 2021 (the “Closing”) and is subject to the Company receiving all necessary regulatory approvals, including the approval of the Toronto Stock Exchange (the “TSX”) to list, on the date of Closing, the Common Shares and the Common Shares issuable upon exercise of the Warrants thereon. The Company agreed to use its commercial reasonable efforts to list the Warrants on the TSX on the date of Closing.

This press release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws.

About Theratechnologies

Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company’s website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.

Forward-Looking Information

This press release contains forward-looking statements and forward-looking information, or, collectively, forward-looking statements, within the meaning of applicable securities laws, that are based on our management’s beliefs and assumptions and on information currently available to our management. You can identify forward-looking statements by terms such as “may”, “will”, “should”, “could”, “would”, “outlook”, “believe”, “plan”, “envisage”, “anticipate”, “expect” and “estimate”, or the negatives of these terms, or variations of them.

The forward-looking statements contained in this press release include, but are not limited to, statements regarding the offer and sale of Units, the use of proceeds from the Offering, the exercise by the Underwriters of the Over-Allotment Option, the timing regarding the closing date of the Offering, and the listing of the Common Shares and Warrants on the TSX.

Forward-looking statements are based upon a number of assumptions and include, but are not limited to, the following: the Covid-19 pandemic will have limited adverse effect on the Offering and the timelines to close the Offering, the proceeds from the Offering will be allocated for the activities set forth herein and we will have enough funds to carry out our business plan.

Forward-looking statements are subject to a variety of risks and uncertainties, many of which are beyond our control that could cause our actual results to differ materially from those that are disclosed in or implied by the forward-looking statements contained in this press release. These risks and uncertainties include, among others, the risk that the Offering does not close as a result of certain events triggering the right of the Underwriters to exercise their market out provisions, the TSX not listing the additional Common Shares to be issued under the Offering, a resurgence in the Covid-19 pandemic adversely affecting our activities and those of our suppliers and third-party service providers and the discovery of unwanted adverse side effects from the long-term use of our products leading to a withdrawal or recall of our products.

We refer potential investors to the “Risk Factors” section of our annual information form dated February 24, 2020 available on SEDAR at www.sedar.com and on EDGAR at www.sec.gov as an exhibit to our report on Form 40-F dated February 25, 2020 under Theratechnologies’ public filings for additional risks regarding the conduct of our business and Theratechnologies. The reader is cautioned to consider these and other risks and uncertainties carefully and not to put undue reliance on forward-looking statements. Forward-looking statements reflect current expectations regarding future events and speak only as of the date of this press release and represent our expectations as of that date.

We undertake no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise, except as may be required by applicable law.

For Media Inquiries:

Denis Boucher
Vice President, Communications and Corporate Affairs
[email protected]
514-336-7800

For Investor Inquiries:

Leah Gibson
Senior Director, Investor Relations
[email protected]
617-356-1009



Posted on

Aeromexico requests termination of ASPA and ASSA Collective Bargaining Agreements to labor authorities

PR Newswire

MEXICO CITY, Jan. 11, 2021 /PRNewswire/ –Grupo Aeroméxico, S.A.B. de C.V. (“Aeromexico” or the “Company”) (BMV: AEROMEX) announces that, as a follow up to its previous relevant events dated December 29 and 31, 2020 and January 8, 2021, it has not yet been possible to satisfactorily conclude the negotiations of the Collective Bargaining Agreements (“CBAs”) with the Asociación Sindical de Pilotos Aviadores de México (“ASPA”) and the Asociación Sindical de Sobrecargos de Aviación de México (“ASSA”).

The acceptance, by said unions, of the adjustments presented by the Company to the CBA is essential to: (i) face the adverse financial, operational and structural effects caused globally to the airline industry by the COVID-19 pandemic, (ii) comply with the commitments and objectives required by the DIP lenders under the Senior Debtor in Possession Credit Facility (“DIP Financing”), obtained within the Company’s voluntary financial restructuring process, under Chapter 11 of the Bankruptcy Code of the United States of America, and (iii) comply with the necessary conditions to have access to the next disbursement under Tranche 2 of the DIP Financing, resources that are essential not only to preserve the ordinary course of business but to avoid generalized defaults on Aeromexico’s obligations with financial creditors under the DIP Financing.

Aeromexico was able to obtain an extension to the term provided in the corresponding Credit Agreement, in order to comply with the DIP Financing conditions and obligations. The new term expires on January 27, 2021. However, the serious situation of the pandemic and the consequent continuation of the restrictions derived from the declaration of force majeure issued by government authorities, in Mexico and abroad, continue to reduce the demand for flights and undermine the Company’s finances.

Aeromexico requires ongoing access in a fast and timely manner to the DIP Financing funds to meet its payments and commitments in the ordinary course of business with key suppliers, authorities, and contributors. Consequently, the Company has decided to request termination, due to the fact of force majeure that undoubtedly affects the Company, the current CBA with the ASPA and ASSA unions, which has been duly submitted, on this date, to the competent labor authorities in full compliance with the applicable provisions of the Federal Labor Law (Ley Federal de Trabajo).

Based on the force majeure situation in which Aeromexico is, it has requested termination of the collective bargaining relationship, as well as the individual agreements with a certain number of pilots and flight attendants in order to reflect the new operating reality of the Company. This situation of force majeure has forced Aeromexico to carry out a workforce reduction as a consequence of the decrease in its ordinary activities.

This decision seeks to guarantee the continuity of our operations to continue offering the best possible service to customers, without affecting their rights.

Aeromexico reiterates that it is in the best position to continue conversations with both ASPA and ASSA, within the period indicated above, looking to find schemes that comply with the necessary conditions to continue accessing the available resources. We appreciate all the support received by our contributors and regulatory authorities during our restructuring process.

Aeromexico will continue pursuing, in an orderly manner, the voluntary process of its financial restructuring under the Chapter 11 process, while continuing to operate and offer services to its customers and contracting from its suppliers the goods and services required for operations. Likewise, it will continue using all the available instruments at its disposal to avoid going from the current financial restructuring situation to a liquidation situation, with the consequent loss of the source of employment affecting thousands of direct and indirect jobs.

This press release contains certain forward-looking statements that reflect the current views and/or expectations of the Company and its management with respect to its performance, business and future events. We use words such as “believe,” “anticipate,” “plan,” “expect,”, “intend,” “target,” “estimate,” “project,” “predict,” “forecast,” “guideline,” “should” and other similar expressions to identify forward-looking statements, but they are not the only way we identify such statements. Such statements are subject to a number of risks, uncertainties and assumptions. We caution you that a number of important factors could cause actual results to differ materially from the plans, objectives, expectations, estimates and intentions expressed in this release. The Company is under no obligation and expressly disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

About Grupo Aeromexico Grupo Aeroméxico, S.A.B. de C.V. is a holding company whose subsidiaries are engaged in commercial aviation in Mexico and the promotion of passenger loyalty programs. Aeromexico, Mexico’s global airline, has its main operations center in Terminal 2 of the Mexico City International Airport. Its destination network has reach in Mexico, the United States, Canada, Central America, South America, Asia and Europe. The Group’s current operating fleet includes Boeing 787 and 737 aircraft, as well as the latest generation Embraer 190. Aeromexico is a founding partner of SkyTeam, an alliance that celebrates 20 years and offers connectivity in more than 170 countries, through the 19 partner airlines. Aeromexico created and implemented a Health and Hygiene Management System (SGSH) to protect its clients and collaborators at all stages of its operation.
www.aeromexico.com   www.skyteam.com 

 

Cision View original content:http://www.prnewswire.com/news-releases/aeromexico-requests-termination-of-aspa-and-assa-collective-bargaining-agreements-to-labor-authorities-301205775.html

SOURCE Grupo Aeroméxico, S.A.B. de C.V.

Posted on

Important Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Restaurant Brands International Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit

RADNOR, Pa., Jan. 11, 2021 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP reminds Restaurant Brands International Inc. (NYSE: QSR) (“Restaurant Brands”) investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Southern District of New York against Restaurant Brands on behalf of those who purchased or otherwise acquired Restaurant Brands common stock between April 29, 2019, and October 28, 2019, inclusive (the “Class Period”).


Reminder:


Investors who purchased or otherwise acquired Restaurant Brands common stock


during the Class Period may,



no later than February 19, 2021



, seek to be appointed as a lead plaintiff representative of the class. For additional information or to learn how to participate in this litigation please contact Kessler Topaz Meltzer & Check, LLP (James Maro, Esq. (484-270-1413) or Adrienne Bell, Esq. (484-270-1435)); toll free at (844) 887-9500; via e-mail at

[email protected]; orclick https://www.ktmc.com/restaurant-brands-international-inc-securities-class-action?utm_source=PR&utm_medium=link&utm_campaign=restaurant_brands

Restaurant Brands is a Canadian corporation and headquartered in Toronto, Ontario, Canada. It is one of the world’s largest restaurant chains with over 27,000 Tim Hortons, Burger King, and Popeyes restaurants in more than 100 countries and U.S. territories. On April 24, 2018, Restaurant Brands announced a new strategy designed to improve performance within its Tim Hortons brand. Specifically, the “Winning Together Plan” would focus on three key pillars: restaurant experience; product excellence; and brand communications. Then, on March 20, 2019, Restaurant Brands announced “Tims Rewards” – a new loyalty program for Tim Hortons customers in Canada. Under the Tims Rewards program, customers would be eligible for a free hot brewed coffee, hot tea, or baked good after every seventh paid visit to a participating Tim Hortons restaurant. On April 10, 2019, Restaurant Brands announced that it was expanding the Tims Rewards program to include customers in the United States.

The Class Period commences on April 29, 2019, when Restaurant Brands filed its financial results for the first quarter ended March 31, 2019 with the SEC. Among other things, Restaurant Brands reported 0.5% system-wide year-over-year sales growth for Tim Hortons on system-wide sales of $1.547 billion. The complaint alleges that, throughout the Class Period, the defendants repeatedly touted the implementation and execution of Restaurant Brands’ Winning Together Plan and Tims Rewards loyalty program. On the heels of Restaurant Brands touting the benefits of these initiatives, the company completed two stock offerings on or about August 12, 2019, and September 5, 2019, collectively resulting in proceeds of approximately $3 billion to insiders.

However, on October 29, 2019, the truth about Restaurant Brands’ execution of its Winning Together Plan and Tims Rewards loyalty program was revealed when the company announced disappointing financial results for the third quarter ended September 30, 2019. Among other things, Restaurant Brands reported a 0.1% system-wide year-over-year sales decline for Tim Hortons—representing a 1.4% same-store sales decline—on system-wide sales of $1.774 billion. Following this news, the price of Restaurant Brands common stock declined $2.59 per share, or approximately 4%, from a close of $68.45 per share on October 25, 2019, to close at $64.86 per share on October 28, 2019.

The complaint alleges that, throughout the Class Period, the defendants misrepresented and/or failed to disclose that: (1) Restaurant Brands’ Winning Together Plan was failing to generate substantial, sustainable improvement within the Tim Hortons brand; (2) the Tims Rewards loyalty program was not generating sustainable revenue growth as increased customer traffic was not offsetting promotional discounting; and (3) as a result, the defendants’ statements about Restaurant Brands’ business, operations, and prospects lacked a reasonable basis.

If you wish to discuss this securities fraud class action lawsuit or have any questions concerning this notice or your rights or interests with respect to this litigation, please contact Kessler Topaz Meltzer & Check, LLP (James Maro, Jr., Esq. or Adrienne Bell, Esq.) at (844) 887-9500 (toll free) or (610) 667–7706, or via e-mail at [email protected].

Restaurant Brands investors may, no later than February 19, 2021, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP, or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. In order to be appointed as a lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff. 

Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer & Check, LLP is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). For more information about Kessler Topaz Meltzer & Check, LLP, please visit www.ktmc.com.

CONTACT:

Kessler Topaz Meltzer & Check, LLP
James Maro, Jr., Esq.
Adrienne Bell, Esq.
280 King of Prussia Road
Radnor, PA 19087
(844) 887-9500 (toll free)
(610) 667-7706
[email protected]



Posted on

NEC Releases “WISE VISION Endoscopy” in Europe and Japan

NEC Releases “WISE VISION Endoscopy” in Europe and Japan

– Contributing to early detection of colorectal cancer –

TOKYO–(BUSINESS WIRE)–NEC Corporation (NEC; TOKYO: 6701) today announced the development of “WISE VISION Endoscopy,” an AI diagnosis-support medical device software for colonoscopies, which is being released in Japan today and is expected to soon be available in Europe. This software connects with existing endoscopy equipment as part of using AI to automatically mark potential lesions from images taken during endoscopic procedures.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210111006087/en/

Graphic 1 (Graphic: Business Wire)

Graphic 1 (Graphic: Business Wire)

Colorectal cancer is the most common cancer in Japan (*1), and the second most common in Europe (*2). Colorectal cancer originates from precancerous lesions (colorectal neoplastic polyps) and it is possible to suppress the progression to cancer by detecting and removing lesions at the polyp stage during endoscopy procedures. However, polyps need to be found with the eye of an endoscopist, and are often difficult to detect because of their size and shape, causing approximately 24% (*3) to be missed, thereby delaying detection.

NEC has been working with the National Cancer Center Japan since 2016 to contribute to resolving this issue. NEC has now developed software that can automatically mark potential lesions based on the use of AI to learn from endoscopic images of more than 10,000 lesions, as well as learning from the observations of expert physicians (*4). This software was developed by applying NEC’s AI technologies, “NEC the WISE,” and its face recognition technology, which is highly evaluated by the National Institute of Standards and Technology (*5) in the United States.

Software features include the following:

1. Compatibility with the endoscopy systems of three leading companies and usability in any examination room

This software can be connected to endoscopes from three leading endoscope manufacturers (*6). By simply connecting an existing endoscope to a monitor and terminal equipped with the software, users can start using it immediately. Moreover, since it is compatible with various endoscopes and easy to prepare, systems can be transferred within different rooms and used efficiently wherever there is an examination.

(Shown in Graphic 1)

2. High visibility and flexible interface

The system marks the lesion candidates with a notification sound and marking. Notification sounds, volume, and marker colors can be customized at any time to the user’s preference. The system can be operated intuitively with a high-visibility user interface, allowing users to smoothly proceed with examinations.

Going forward, as a company that creates social value, NEC aims to promote a healthy, and sustainable society, where individuals can thrive from the utilization of advanced IT technologies.

(Shown in Graphic 2)

(*1) According to statistics from the National Cancer Research Center Japan (Japanese text only)

https://ganjoho.jp/reg_stat/statistics/stat/summary.html

(*2) According to United European Gastroenterology

https://ueg.eu/p/78#

(*3) Rex DK, Cutler CS, Lemmel GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997;112(1):24-28

(*4) Yamada M, Saito Y, Imaoka H, et al. Development of a real-time endoscopic image diagnosis support system using deep learning technology in colonoscopy. Sci Rep. 2019;9:14465

(*5) NEC Face Recognition Technology Ranks First in NIST Accuracy Testing

https://www.nec.com/en/press/201910/global_20191003_01.html

(*6) Connectivity and operations have been confirmed with the following endoscopes

– Olympus EVIS LUCERA ELITE Video System Center CV-290

– FUJIFILM ELUXEO video processor VP-7000

– PENTAX Medical OPTIVISTA EPK-i7010 video processor

Product name: WISE VISION Endoscopy

***

About NEC Corporation

For more information, visit NEC at www.nec.com.

Press Contact:

Joseph Jasper

NEC Corporation

j-jasper(@)nec.com

+81-3-3798-6511

 

KEYWORDS: North America United States Asia Pacific Europe Japan

INDUSTRY KEYWORDS: Technology Surgery Medical Devices Hospitals Software Networks Hardware Health Oncology

MEDIA:

Logo
Logo
Photo
Photo
Graphic 1 (Graphic: Business Wire)
Photo
Photo
Graphic 2 (Source: National Cancer Center Hospital)
Posted on

Vonage Partners with Wall Street English to Power Digital Classrooms

Vonage Partners with Wall Street English to Power Digital Classrooms

  • Vonage’s Video API powers Wall Street English’s online educational solutions
  • Digital communications a critical means of providing educational services in response to COVID-19

SINGAPORE–(BUSINESS WIRE)–Vonage (Nasdaq: VG), a global leader in cloud communications helping businesses accelerate their digital transformation, has been chosen by English language education company Wall Street English to power its digital classroom platform for customers worldwide.

With social distancing and safety measures in place around the globe, the education industry had to adjust overnight to a new, virtual, reality. This led Wall Street English to launch its digital classroom platform to give students continued access to their courses and teachers the ability to conduct classes online.

The Vonage Video API, embedded within Wall Street English’s platform, enables students and teachers to have live, engaging and interactive video classes, creating an environment similar to an in-person classroom experience. Students can even interact with their teacher and fellow students like they would in a traditional classroom.

Established in 1972, Wall Street English has an alumni community surpassing three million, with a current enrollment of 175,000 students. Using a franchise model, the company operates over 350 centers in 28 countries across North Africa, East Asia, Southeast Asia, Europe, Latin America, and the Middle East.

“During this difficult time, our priority is the health and safety of our students, staff and the communities in which we operate,” said David Kedwards, CEO of Wall Street English. “We also want to ensure that our students have continued access to their courses and the flexibility to study anytime, across multiple devices.

“The decision to move online in addition to our brick-and-mortar centers is a great step forward for the company, evolving our business to meet the needs of today’s learners. Vonage has played an important role in our digital transformation. The Vonage Video API integrated easily with our platform, enabling us to set up real-time, high-quality video classes to serve thousands of students worldwide.”

A recent Vonage report tracking communications usage before the pandemic and again in August 2020 revealed that 39 percent of the 5,000 global consumers surveyed reported higher engagement with education technology tools. Findings also showed that 42 percent of that same group preferred the use of video when engaging with other students and teachers in a virtual classroom. Among consumers in Asia-Pacific, 44 percent reported higher engagement with educational applications since COVID-19.

“COVID-19 has accelerated the need for reliable and high-quality video offerings to facilitate the remote delivery of vital services like education. Virtual and hybrid options that provide safe and uninterrupted education experiences are now crucial for both students and teachers to have continued access to education,” said Sunny Rao, Vonage Senior Vice President and General Manager for the Asia Pacific region.

“We are proud to support Wall Street English’s digital transformation, leveraging Vonage to embed secure, rich video capabilities to its online platform for customers,” he added.

With an ever-growing network of more than one million registered developers, the Vonage Communications Platform makes it easy for businesses to use APIs to disrupt their industries, and enable the type of business continuity, remote work, and remote delivery of services that is so essential in today’s environment. Vonage APIs allow developers to easily enhance and build innovative customer experiences directly into their existing applications and devices. The Vonage Communications Platform offers a full suite of programmable voice, video, messaging, and email services to forward-thinking businesses worldwide. Through its partners, Vonage’s platform is at the center of many notable transformational projects in the APAC region, and a de facto for startups.

To find out more about Vonage, visit www.vonage.com.

###

About Vonage

Vonage, (Nasdaq: VG) a global cloud communications leader, helps businesses accelerate their digital transformation. Vonage’s Communications Services Platform is fully programmable and allows for the integration of Video, Voice, Chat, Messaging and Verification into existing products, workflows and systems. Vonage’s fully programmable unified communications and contact center applications are built from the Vonage platform and enable companies to transform how they communicate and operate from the office or anywhere, providing enormous flexibility and ensuring business continuity.

Vonage Holdings Corp. is headquartered in New Jersey, with offices throughout the United States, Europe, Australia and Asia. To follow Vonage on Twitter, please visit www.twitter.com/vonage. To become a fan on Facebook, go to facebook.com/vonage. To subscribe on YouTube, visit youtube.com/vonage.

About Wall Street English

Wall Street English is a leading global provider in English training for adults, with over 350 learning centers in 29 territories. Since 1972 it has provided tuition to over three million adults with a current enrolment of over 175,000 students.

Wall Street English combines a proven and effective blended learning methodology with a scalable business model to capitalize on the growth potential of adult English language learning, including both center-based and online training. With ongoing investment in product and model development, such as the recent adoption of online solutions, the company is well positioned to expand further and respond to market dynamics, students needs and technological changes.

To follow Wall Street English on Twitter, please visit: www.twitter.com/WSE_Global and on LinkedIn: www.linkedin.com/company/wall-street-english.

Vonage Media Contact

Elise Leonard

+1 732-837-3801

[email protected]

Vonage Investor Contact

Hunter Blankenbaker

+1 732-444-4926

[email protected]

KEYWORDS: Asia Pacific Singapore

INDUSTRY KEYWORDS: Education Technology VoIP Audio/Video Continuing Internet Training

MEDIA:

Logo
Logo
Posted on

MIC Announces Conversion Ratio Adjustment to Convertible Senior Notes Due 2023

MIC Announces Conversion Ratio Adjustment to Convertible Senior Notes Due 2023

  • Conversion ratio increased to 12.6572shares
  • Increase reflects impact of special dividend

NEW YORK–(BUSINESS WIRE)–
Macquarie Infrastructure Corporation (NYSE: MIC) announced an adjustment to the conversion ratio applicable to its 2.00% Convertible Senior Notes due 2023. The conversion ratio for the Notes increased to 12.6572 shares of common stock per $1,000 of principal amount. The increase is effective January 11, 2021. This adjustment reflects the impact of the special dividend paid by the Company on January 8, 2021 to holders of its common stock.

About MIC

MIC owns and operates businesses providing basic services to customers in the United States. Its businesses consist of an airport services business, Atlantic Aviation, and entities comprising an energy services, production and distribution segment, MIC Hawaii. For additional information, please visit the MIC website at www.macquarie.com/mic.

MIC is not an authorized deposit-taking institution for the purposes of the Banking Act 1959 (Commonwealth of Australia). The obligations of MIC do not represent deposits or other liabilities of Macquarie Bank Limited ABN 46 008 583 542 (MBL). MBL does not guarantee or otherwise provide assurance in respect of the obligations of MIC.

Investors

Jay A. Davis

Investor Relations

MIC

+1 212-231-1825

Media

Lee Lubarsky

Corporate Communications

MIC

+1 212-231-2638

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Posted on

Medley LLC Retains B. Riley to Conduct Strategic Review of Bonds

PR Newswire

NEW YORK, Jan. 11, 2021 /PRNewswire/ — Medley LLC (the “Company”) announced today that the Company has engaged B. Riley Securities Inc. (“B. Riley”) as its investment banking advisor to assist in analyzing various strategic financial alternatives to address its capital structure, including strategic and financing alternatives to restructure its indebtedness and other contractual obligations. Medley LLC has outstanding unsecured bonds which trade on the NYSE under the symbols (NYSE: MDLX) and (NYSE: MDLQ).

B. Riley Securities is an affiliate of B. Riley Financial, Inc.

There can be no assurance that this review will result in any particular outcome.


About Medley

Medley is an alternative asset management firm offering yield solutions to retail and institutional investors.  Medley’s national direct origination franchise is a premier provider of capital to the middle market in the U.S.  As of September 30, 2020, Medley had $3.4 billion of assets under management in two business development companies, Medley Capital Corporation (NYSE: MCC) and Sierra Income Corporation, and several private investment vehicles. Over the past 18 years, Medley has provided capital to over 400 companies across 35 industries in North America.(1) 


Forward-Looking Statements

This press release contains “forward-looking” statements. Such forward-looking statements reflect current views with respect to future events and financial performance. Statements that include the words “should,” “would,” “expect,” “intend,” “plan,” “believe,” “project,” “anticipate,” “seek,” “will,” and similar statements of a future or forward-looking nature identify forward-looking statements in this material or similar statements for purposes of the U.S. federal securities laws or otherwise. Because forward-looking statements include risks and uncertainties, actual results may differ materially from those expressed or implied. Important factors that could cause actual results to differ materially from the expectations reflected in the forward-looking statements include, but are not limited to: those discussed in the Company’s filings with the Securities and Exchange Commission; and uncertainties associated with the impact from the ongoing COVID-19 pandemic.

The foregoing review of important factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in the “Risk Factors” and other sections of the Company’s most recent Annual Report on Form 10-K and most recent Quarterly Reports on Form 10-Q. The forward-looking statements in this press release represent the Company’s views as of the date of hereof. The Company anticipates that subsequent events and developments will cause its views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company does not have any current intention of doing so except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing the Company’s views as of any date subsequent to the date of this material.


Available Information

Medley LLC’s filings with the Securities and Exchange Commission, press releases, earnings releases and other financial information are available at www.mdly.com.

Investor Contact:

Sam Anderson

Head of Capital Markets & Risk Management
Medley LLC
212-759-0777

Media Contact:

Jonathan Gasthalter/Nathaniel Garnick 
Gasthalter & Co. LP 
212-257-4170

1 Assets under management refers to assets of our funds, which represents the sum of the net asset value of such funds, the drawn and undrawn debt (at the fund level, including amounts subject to restrictions) and uncalled committed capital (including commitments to funds that have yet to commence their investment periods). Medley Capital Corporation represented $0.3 billion of the Company’s total assets under management as of September 30, 2020 and these assets were internalized at Medley Capital Corporation as of January 1, 2021.

 

Cision View original content:http://www.prnewswire.com/news-releases/medley-llc-retains-b-riley-to-conduct-strategic-review-of-bonds-301205759.html

SOURCE Medley LLC

Posted on

Gannex Announces Positive Phase I Clinical Results on Its THR-β Agonist ASC41

Doses Selected for Phase 2 Trial in Patients with NASH

PR Newswire

SHANGHAI, Jan. 11, 2021 /PRNewswire/ — Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672) and fully dedicated to the R&D and commercialization of new drugs in the field of non-alcoholic steatohepatitis (NASH), today announces the positive phase I clinical results of ASC41 oral tablet, a liver-targeted prodrug. The active metabolite of ASC41 is a selective thyroid hormone receptor beta (THR-β) agonist.

This phase I trial is a randomized, double-blind, placebo controlled single- and multiple-ascending dose study in 65 subjects with elevated low-density lipoprotein cholesterol (LDL-C) (> 110 mg/dL), a population characteristic of non-alcoholic fatty liver disease (NAFLD). ASC41 has been formulated in commercially ready oral tablets developed in-house using proprietary technology. In the single-ascending dose portion of the study, preliminary data suggest that ASC41 is safe and well tolerated up to a dose of 20 mg. Furthermore, ASC41 tablet formulation showed a dose-proportional pharmacokinetic profile from 1 mg to 20 mg. In the multiple-ascending dose (MAD) portion of the study, preliminary data suggest that after 14 days of once daily oral dosing, subjects demonstrate clinically meaningful and statistically significant reduction in LDL-C and triglycerides compared to placebo, as shown in the table below.

 

Placebo-adjusted relative change (mean) from baseline after 14 days of once daily
oral dosing of ASC41 tablets

1 mg 
(n=12)

2 mg 
(n=12)

5 mg 
(n=12)

Placebo-adjusted LDL-C reduction


P-value vs placebo

-0.42%


p=0.947

-11.94%


p=0.052

-19.99%


p=0.002

Placebo-adjusted triglyceride reduction


P-value vs placebo

-39.43%


p=0.002

-31.06%


p=0.029

-34.49%


p=0.015

 

ASC41 had a benign adverse event profile at all doses following 14-day treatment, with no grade 3 or above adverse events, no serious adverse events or premature discontinuations. Furthermore, ASC41 tablet formulation displayed a dose-proportional pharmacokinetic profile from 1 mg to 5 mg following once daily, 14-day dosing.

“We are pleased with the excellent pharmacokinetic profile using our in-house developed tablet formulation”, said Handan He, PhD, Chief Scientific Officer of Ascletis, “The successful development of the commercially-ready oral formulation at this early stage will accelerate our clinical development.”

“We are excited about the LDL-C and triglyceride reductions in this patient population characteristic of NAFLD, at low doses of ASC41,” said Melissa Palmer, MD, Chief Medical Officer of Gannex, “These results support advancement of the ASC41 clinical program for the indication of NASH.”

About Ascletis

Ascletis is an innovative R&D driven biotech and listed on Hong Kong Stock Exchange (1672.HK). Ascletis is committed to developing and commercializing innovative drugs in the areas of viral hepatitis, NASH and HIV/AIDS for unmet medical needs in China and globally. Led by a management team with deep expertise and a proven track record, Ascletis has developed into a fully integrated platform covering the entire value chain from discovery and development to manufacturing and commercialization.

Ascletis has three marketed products and thirteen R&D pipeline drug candidates or combination therapies (nine of them developed in-house). 1. Viral hepatitis: (i) Hepatitis B: focus on breakthrough therapies for HBV clinical cure with subcutaneously injected PD-L1 antibody – ASC22 and Pegasys® as cornerstone drugs. (ii) Hepatitis C: successfully launched all oral regimen of ASCLEVIR® and GANOVO® combination (RDV/DNV regimen); and ASC18 fixed dose combination (FDC) is an upgraded version of RDV/DNV regimen with bridging study finished. 2. NASH: Gannex, a wholly-owned company of Ascletis, is fully dedicated to the R&D and commercialization of new drugs in the field of NASH. Gannex has three clinical stage drug candidates against three different targets – FASN, THR-beta and FXR, and three pre-clinical stage combination therapies. 3. HIV/AIDS: ASC09F is a FDC treatment of HIV targeting protease. The clinical trial application of ASC09F has been approved. For more information, please visit www.ascletis.com.

Cision View original content:http://www.prnewswire.com/news-releases/gannex-announces-positive-phase-i-clinical-results-on-its-thr–agonist-asc41-301205745.html

SOURCE Ascletis Pharma Inc.

Posted on

Verizon, UPS, and Skyward announce connected drone delivery at CES 2021

PORTLAND, Ore., Jan. 11, 2021 (GLOBE NEWSWIRE) — Skyward, A Verizon company, and UPS Flight Forward today announced collaborative efforts to deliver retail products with drones connected to Verizon 4G LTE, as well as 5G testing and integration for delivery. The companies aim to deliver retail products via connected drones at The Villages in Florida.

“We will need the ability to manage and support multiple drones, flying simultaneously, dispatched from a centralized location, operating in a secure and safe environment. To do this at scale, alongside Verizon and Skyward, we’ll need the power of 5G,” said Carol B. Tomé, CEO of UPS.

“We’re just beginning to see how the power of 5G Ultra Wideband will transform the way businesses operate,” said Rima Qureshi, Chief Strategy Officer at Verizon. “By partnering with UPS and other innovative companies, we can learn from each other’s expertise and collaborate to create solutions that help move the world forward.”

In 2020, Verizon, UPS Flight Forward, and Skyward started testing 4G LTE in delivery drones to demonstrate cellular reliability and performance at altitude.

“The low latency of 5G and edge compute is ideal for monitoring air traffic in and out of a busy logistics hub, especially those using mixed fleets of autonomous vehicles like drones, trucks, and planes,” said Mariah Scott, Skyward President. “This year, we’ll be taking the collaboration with UPS further by testing 5G Ultra Wideband integrations to connect the sky.”

UPS has operated more than 3,800 successful drone delivery flights since the creation of UPS Flight Forward, its drone delivery company, certified by the Federal Aviation Administration in 2019. But in 2020, drone delivery emerged as much more than rapid delivery of essential healthcare items — during the global pandemic it provided high-risk seniors a rapid and contactless delivery option to remain healthy at home.

“Using Verizon’s 5G and Skyward, we’ll be able to transform the delivery experience – more personal, more on-demand and with the same safety, efficiency, and reliability our customers trust today,” said Bala Ganesh, Vice President, Advanced Technology Group at UPS.

About Verizon:
Verizon Communications Inc. (NYSE, Nasdaq: VZ) was formed on June 30, 2000 and is celebrating its 20th year as one of the world’s leading providers of technology, communications, information and entertainment products and services. Headquartered in New York City and with a presence around the world, Verizon generated revenues of $131.9 billion in 2019. The company offers data, video and voice services and solutions on its award-winning networks and platforms, delivering on customers’ demand for mobility, reliable network connectivity, security and control.

VERIZON’S ONLINE MEDIA CENTER: News releases, stories, media contacts and other resources are available at https://www.verizon.com/about/media-center. News releases are also available through an RSS feed. To subscribe, visit www.verizon.com/about/rss-feeds/.

Media contact: 

Jess Moody
[email protected]
907-602-3313